Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
influenza A H9N2 vaccine
- Development stage
- Unknown
- Lead developer
- Intervet
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous, Intranasal
01
Overview
Influenza A H9N2 vaccine is a vaccine developed to provide protection against the H9N2 subtype of avian influenza virus. It exists in multiple formulations including inactivated vaccines, live attenuated vaccines, and subunit vaccines. The H9N2 subtype is a strain of avian influenza that has caused human infections and is considered to have pandemic potential. Different formulations of the vaccine work by stimulating an immune response to the hemagglutinin (HA) protein of the H9N2 virus, which helps the body develop antibodies that can recognize and fight future infections with this virus strain.
- Brand names
- Nobilis Influenza H9N2
- Other names
- A/H9N2 influenza vaccineH9N2 vaccineH-9N2 vaccineH 9N2 vaccineH9 HA subunit vaccineH-9 HA subunit vaccineH 9 HA subunit vaccine
Beyond the preview
Go deeper on influenza A H9N2 vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on influenza A H9N2 vaccine.